Compare ECF & BHST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | ECF | BHST |
|---|---|---|
| Founded | 1986 | 2007 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | |
| Sector | Finance | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 161.3M | 137.1M |
| IPO Year | N/A | N/A |
| Metric | ECF | BHST |
|---|---|---|
| Price | $12.06 | $5.01 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $14.00 |
| AVG Volume (30 Days) | ★ 57.7K | 55.1K |
| Earning Date | 01-01-0001 | 11-13-2025 |
| Dividend Yield | ★ 6.42% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.46 | N/A |
| Revenue | N/A | ★ $32,720,000.00 |
| Revenue This Year | N/A | $116.40 |
| Revenue Next Year | N/A | $55.91 |
| P/E Ratio | $17.61 | ★ N/A |
| Revenue Growth | N/A | ★ 45.88 |
| 52 Week Low | $7.02 | $4.72 |
| 52 Week High | $8.91 | $12.80 |
| Indicator | ECF | BHST |
|---|---|---|
| Relative Strength Index (RSI) | 59.05 | 38.66 |
| Support Level | $11.85 | $5.08 |
| Resistance Level | $12.03 | $5.60 |
| Average True Range (ATR) | 0.18 | 0.33 |
| MACD | 0.04 | 0.08 |
| Stochastic Oscillator | 84.38 | 11.59 |
Ellsworth Growth and Income Fund Ltd operate as a closed-end, diversified management investment company. Its investment objective is to provide income and the potential for capital appreciation, which objectives the Fund considers to be relatively equal over the long term due to the nature of the securities in which it invests. The company invests in convertible and equity securities. It invests in various sectors, such as healthcare, financial services, computer software and services, energy and utilities, real estate investment trusts, semiconductors, telecommunications, business services, food and beverage, consumer products, transportation, consumer services among others.
BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. This company is the industrial large-scale plant cell growth technology capable of directly and constantly producing active plant ingredients without the necessity to grow the plant itself. The company is focused on leveraging its botanical synthesis technology to develop the next generation of science-based and clinical therapeutic solutions, within two business verticals - nutraceutical health and wellness products such as dietary supplements, and the development of plant cell-based Active Pharmaceutical Ingredients (APIs) that focus on specific medical indications.